PureTech Health Announces Acquisition of Founded Entity
Ticker: PTCHF · Form: 6-K · Filed: Mar 18, 2024 · CIK: 1782999
| Field | Detail |
|---|---|
| Company | Puretech Health PLC (PTCHF) |
| Form Type | 6-K |
| Filed Date | Mar 18, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $14 Billion |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, press-release
Related Tickers: PRTC
TL;DR
PureTech Health just got acquired, big news for PRTC holders.
AI Summary
On March 18, 2024, PureTech Health plc announced the acquisition of its founded entity, a significant development for the company. The press release details this acquisition, marking a key event in PureTech Health's strategic operations for March 2024.
Why It Matters
This acquisition represents a major strategic move for PureTech Health, potentially impacting its future growth and portfolio value.
Risk Assessment
Risk Level: medium — Acquisitions can be complex and their success is not guaranteed, introducing potential risks to the company's financial performance and stock value.
Key Players & Entities
- PureTech Health plc (company) — Filer of the 6-K report and acquirer
- March 18, 2024 (date) — Date of the press release announcing the acquisition
FAQ
What is the name of the founded entity that PureTech Health plc is acquiring?
The provided text states that PureTech Health plc is acquiring 'its Founded Entity' but does not specify the name of that entity.
What is the financial value or terms of the acquisition?
The provided text announces the acquisition but does not disclose any specific financial details or terms of the deal.
When was the press release announcing the acquisition issued?
The press release announcing the acquisition was issued on March 18, 2024.
What is PureTech Health plc's stock ticker symbol?
PureTech Health plc's stock ticker symbols are LSE: PRTC and Nasdaq: PRTC.
Does this filing indicate if PureTech Health plc files annual reports on Form 20-F or 40-F?
Yes, the filing indicates that PureTech Health plc files annual reports under cover of Form 20-F.
Filing Stats: 266 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2024-03-18 16:30:51
Key Financial Figures
- $14 Billion — Founded Entity Karuna Therapeutics for $14 Billion. SIGNATURES Pursuant to the require
Filing Documents
- d794093d6k.htm (6-K) — 9KB
- d794093dex991.htm (EX-99.1) — 24KB
- 0001193125-24-070190.txt ( ) — 34KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PURETECH HEALTH PLC Date: March 18, 2024 By: /s/ Daphne Zohar Name: Daphne Zohar Title: Chief Executive Officer